About the Company
Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $RTRX News
Buy Rating Affirmed for Travere Therapeutics on Strong FILSPARI Data and Favorable Regulatory Outlook
Ed Arce, an analyst from H.C. Wainwright, maintained the Buy rating on Travere Therapeutics (TVTX – Research Report). The associated ...
We don't have any news on Retrophin, Inc. at the moment.
Loading the latest forecasts...